“Simplicity is the ultimate sophistication”

– Leonardo da Vinci

About AOS

AOS is an award winning dynamic ophthalmic software development company established in 2014.

AOS’s core drive is to facilitate the advent of newer technologies in the ophthalmic market by providing intuitive, diagnostic tools to aid clinicians.

AOS is based in London.

Medical device classification:

AOS Anterior & AOS Posterior have both been classified as Class I Medical Devices (rule 12 MDD) according to MEDDEV 93/42/EEC

FDA Approved Class 1 Medical Device reg no. 3014329625

TGA Approved Class 1 Medical Device ARTG id. 295522

ANVISA Approved CLASSE : II 80891629004

Quality Management System:

AOS has implemented a full QMS and is committed to achieving ISO13485

Awards:

Seal of Excellence – H2020 European Commission 2016 – Fundus 2.0.

You can view the certificate by clicking here.

Introduction to AOS

Dr Eduardo Mangieri

Chairman of the Board
CEO

Karl Hans Jeebaun

Executive Director
Commercial Director

Gerard Kool

Operations

Professor Nicola Pescosolido

Executive Director
Medical Advisor

Dr John Gelles, O.D., F.I.A.O., F.C.L.S.A., F.S.L.S

Medical Advisor

Dr Sandip Doshi, PhD BSc MCOptom

Medical Advisor

Michael Cheng

Software Engineer